The correlation between p16 expression and INK4a locus mutation with grades and stages in oral squamous cell carcinoma

Indian Journal of Pathology and Microbiology

Volumn 57, Issue 1, 2014, Pages 24-30

  Sargolzaei, Soudabeh ^a   Farhadi, Sareh ^b   Kazemi, Bahram ^a   Bandehpour, Mojgan ^a   Kharazifard, Mohammad Javad ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

grade; Oral squamous cell carcinoma; stage

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P16;

ADULT; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 9P; CLINICAL INDICATOR; CONFORMATION SENSITIVE GEL ELECTROPHORESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GEL ELECTROPHORESIS; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; BIOSYNTHESIS; ELECTROPHORESIS; GENETICS; MOUTH TUMOR; MUTATION; SEVERITY OF ILLNESS INDEX; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ELECTROPHORESIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 84899465554     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.130877     Document Type: Article

References (41)

1. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001;132:7-11.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Acha A, Ruesga MT, Rodríguez MJ, Martínez de Pancorbo MA, Aguirre JM. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal 2005;10:95-102.
4. Maruya S, Issa JP, Weber RS, Rosenthal DI, Haviland JC, Lotan R, El-Naggar AK. Differential methylation status of tumor-associated genes in head and neck squamous cell carcinoma: Incidence and potential implications. Clin Cancer Res 2004;10:3825-30.
5. Perez-Otdonez B, Beauchemin M, Jordan RC. Molecular biology of Squamous cell carcinoma of head and neck. J Clin Pathol 2006;59:445-53.
6. Chin L, Pomerantz J, Depinho RA. The INK4a/ARF tumor suppressor: One gene-two product pathways. Trends Biochem Sci 1998;23:291-6.
7. Serraono M, Hannan GJ, Beach D. Anew regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
8. Paradiso A, Ranieri G, Stea B, Zito A, Zehbe I, Tommasino M, et al. Altered p16 INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Int J Oncol 2004;24:249-55.
9. Driemel O, Müller-Richter UD, Hakim SG, Bauer R, Berndt A, Kleinheinz J, et al. Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma. Head Face Med 2008;4:17-9.
10. Regezi JA, Sciubba JJ and Jordan RCK. Oral Pathology. 5 th ed, Saunders: Elsevier; 2008. p. 388-9.
11. Robbins and Cotran pathologic basis of disease. 7 th ed. Saunders: Elsevier; 2005. p. 288-92.
12. Kumar R, Sauroja I, Punnonen K, Jansen C and Hemminki K. Selective deletion of exon 1 beta of the p19 ARF gene in metastatic melanoma cell lines. Genes Chromosomes Cancer 1998;23:273-7.
13. Kamb A. Cyclin-dependent kinase inhibitors and human cancer. Curr Top Microbiol Immunol 1998;227:139-48.
14. Gonzales MV, Pello MF, Lopez-Larrea C, Squarez C, Mendez NJ, Coto E. Loss of heterozygosity and mutation analysis of the p16(9p21) and p53(17p13) genes in Squamous cell carcinoma of the head and neck. Clin Cancer Res 1994;1:1043-9.
15. Van der Reit P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1994;54:1156-8.
16. Tsai CH, Yang CC, Chou LS, Chou MY. The correlation between alteration of p16gene and clinical status in oral squamous cell carcinoma. J Oral Path Med 2001;30:527-31.
17. Teresa Ruesga M, Acha-Sagredo A et al. p16 INK4A promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients.Cancer Letters 2007; 250:140-145.
18. Kato K, Hara A, et al. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and surrounding normal mucosa. J Cancer Res Clin Oncol 2006; 132:735-743.
19. Shintani S, Nakahara Y, et al. Inactivation of p14 ARF, p15 INK4B and p16 INK4A genes is a frequent event in human oral squamous cell carcinoma. Oral Oncology 2001;37:498-504.
20. Sartor M, Steingrimsdottir H, et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. British Journal of cancer.1999;80:79-86.
21. Suzuki H, Sugimura H, et al. p16 INK4A in oral squamous cell carcinomas-A correlation with biological behaviors: Immunohistochemical and FISH analysis.J Oral Maxillofac Surg 2006;64:1617-1623.
22. Poi MJ, Yen T,et al. Somatic INK4a-ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.Molecular Carcinogenesis 2001;30:26-36.
23. Weber A, Bellmann U et al, INK4a-ARF alternations and p53 mutations in primary and consecutive squamous cell carcinoma of head and neck, Vichows Arch 2002, 441:133-142.
24. Pande P, Mathur M, et al. pRb and p16 protein alterations in human oral tumorigenesis Oral Oncol. 1998 Sep;34:396-403.
25. Vairaktaris E, Yapijakis C, Psyrri A, Spyridonidou S, Yannopoulos A, Lazaris A, et al. Loss of tumor suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res 2007;27:979-84.
26. Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, et al. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 2005;68:314-25.
27. Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T. High frequency of homozygous deletion and methylation of p14ARF gene in oral squamous cell carcinomas. Cancer 2001;163:221-8.
28. Buajeeb W, Poomsawat S, Punyasingh J, Sanguansin S. Expression of p16 in oral cancer and premalignant lesions. J Oral Pathol Med 2009;38:104-8.
29. Chen Q, Luo G, Li B, Samaranayake LP. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: A semi-quantitive immunohistochemical study. J Oral Path Med 1999;28:158-64.
30. Tokman B, Gultekin SE, Sezer C, Alpar R. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system. Saudi Med J 2004; 25:1922-30.
31. Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, et al. Somatic INK4a-ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog 2001;30:26-36.
32. Nakahara Y, Shintani S, et al. High frequency of homozygous deletion and methylation of p14ARF gene in oral squamous cell carcinomas.Cancer 2001;163:221-228.
33. Ohta S, Uemura H, et al. Alteration of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Path Oral Endod 2009;107:81-91.
34. Smeds J,Berggren P, et al.Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: The CDKN2A (p16 INK4A and p14 ARF) and p53 genes are major targets for inactivation.Carcinogenesis 2002;23:645-655.
35. Carins P,Mao L, et al. Rate of p16(MTS1) mutation in primary tumors with 9p loss. Science 1999;265:415-416.
36. Reed AL, Califano J, et al. High frequency of p16 (CDK2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cacer Res 1996;56:3630-3633.
37. Law JC, Ishwad C, et al. Deletion and mutational inactivation of the cyclin-dependent kinase-4 inhibitor gene (p16)in oral carcinoma.Am J Hum Genet 1994;55:34.
38. Zhang S Y, Klein-Szanto AJP, et al. Higher frequency of alteration in the p16/CDK2 gene in squamous cell carcinoma cell lines than in primary tumor of the head and neck. Cancer Res 1994;54:5050-5053.
39. Uzawa K, Suzuki H, et al. Mutational state of p16/CDK2 and VHL genes in squamous cell carcinoma of the oral cavity. Int J Onco 1995;7:895-899.
40. Kannan K, Munirajan AK, et al. The p16INK4alpha/p19ARF gene mutations in Indian oral squamous cell carcinomas. Int J Onco 2000;16:585-590.
41. Ohta S, Uemura H, et al. Alteration of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Path Oral Endod 2009;107:81-91.